Tidal Investments LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the 3rd quarter, Holdings Channel reports. The fund bought 70,000 shares of the company’s stock, valued at approximately $9,012,000.
A number of other hedge funds have also added to or reduced their stakes in the business. Foundations Investment Advisors LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 13.0% during the 3rd quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after buying an additional 530 shares during the period. SG Americas Securities LLC boosted its stake in Direxion Daily S&P Biotech Bull 3x Shares by 49.3% during the third quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock worth $412,000 after acquiring an additional 1,057 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth $43,000. Headlands Technologies LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at $68,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the second quarter valued at about $596,000.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
Shares of LABU opened at $104.87 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a one year low of $80.41 and a one year high of $176.99. The stock has a 50-day moving average of $122.93 and a 200-day moving average of $124.14.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Quiet Period Expirations Explained
- Why a Stock Split Could Be a Game-Changer for Casey’s in 2025
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Where to Invest in 2025: Top Stock Picks for Maximum Gains
- What Are Dividend Contenders? Investing in Dividend Contenders
- Investment Opportunity of 2025: Why Braze Stock Stands Out
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
